Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Journal of Clinical Pharmacology
|
March 29, 2014
A single-dose, open-label, parallel, randomized, dose-proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia
Adriaan Cleton, Stefaan Rossenu, Herta Crauwels, et al.
Annals of General Psychiatry
|
November 6, 2023
Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder
David Hough, Alice R Mao, Michael Aman, et al.
The International Journal of Neuropsychopharmacology
|
August 30, 2020
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
Dawn F Ionescu, Dong-Jing Fu, Xin Qiu, et al.
British Journal of Clinical Pharmacology
|
June 23, 2016
Prospective dose selection and acceleration of paliperidone palmitate 3-month formulation development using a pharmacometric bridging strategy
Mahesh N Samtani, Partha Nandy, Paulien Ravenstijn, et al.
Current Medical Research and Opinion
|
June 7, 2016
Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia
Phillip Pierce, Srihari Gopal, Adam Savitz, et al.
The American Journal of Psychiatry
|
April 17, 2018
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M Canuso, Jaskaran B Singh, Maggie Fedgchin, et al.
Focus (American Psychiatric Publishing)
|
February 5, 2020
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M Canuso, Jaskaran B Singh, Maggie Fedgchin, et al.
Radiology
|
October 21, 2010
Appropriate patient selection at abdominal dual-energy CT using 80 kV: relationship between patient size, image noise, and image quality
Luís S Guimarães, Joel G Fletcher, William S Harmsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2002
Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging
Susan M Galbraith, Gordon J S Rustin, Martin A Lodge, et al.
Neuropsychiatric Disease and Treatment
|
September 2, 2017
Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study
Adam J Savitz, Haiyan Xu, Srihari Gopal, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Journal of Clinical Pharmacology
|
March 29, 2014
A single-dose, open-label, parallel, randomized, dose-proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia
Adriaan Cleton, Stefaan Rossenu, Herta Crauwels, et al.
Annals of General Psychiatry
|
November 6, 2023
Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder
David Hough, Alice R Mao, Michael Aman, et al.
The International Journal of Neuropsychopharmacology
|
August 30, 2020
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
Dawn F Ionescu, Dong-Jing Fu, Xin Qiu, et al.
British Journal of Clinical Pharmacology
|
June 23, 2016
Prospective dose selection and acceleration of paliperidone palmitate 3-month formulation development using a pharmacometric bridging strategy
Mahesh N Samtani, Partha Nandy, Paulien Ravenstijn, et al.
Current Medical Research and Opinion
|
June 7, 2016
Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia
Phillip Pierce, Srihari Gopal, Adam Savitz, et al.
The American Journal of Psychiatry
|
April 17, 2018
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M Canuso, Jaskaran B Singh, Maggie Fedgchin, et al.
Focus (American Psychiatric Publishing)
|
February 5, 2020
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M Canuso, Jaskaran B Singh, Maggie Fedgchin, et al.
Radiology
|
October 21, 2010
Appropriate patient selection at abdominal dual-energy CT using 80 kV: relationship between patient size, image noise, and image quality
Luís S Guimarães, Joel G Fletcher, William S Harmsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2002
Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging
Susan M Galbraith, Gordon J S Rustin, Martin A Lodge, et al.
Neuropsychiatric Disease and Treatment
|
September 2, 2017
Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study
Adam J Savitz, Haiyan Xu, Srihari Gopal, et al.
Page
of 7